Search Results - "San Bartolome, Clara"

  • Showing 1 - 15 results of 15
Refine Results
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6

    Immune-Mediated Mechanisms in Cofactor-Dependent Food Allergy and Anaphylaxis: Effect of Cofactors in Basophils and Mast Cells by Muñoz-Cano, Rosa, San Bartolome, Clara, Casas-Saucedo, Rocío, Araujo, Giovanna, Gelis, Sonia, Ruano-Zaragoza, Maria, Roca-Ferrer, Jordi, Palomares, Francis, Martin, Margarita, Bartra, Joan, Pascal, Mariona

    Published in Frontiers in immunology (17-02-2021)
    “…Cofactors may explain why in some cases food ingestion leads to anaphylaxis while in others elicits a milder reaction or tolerance. With cofactors, reactions…”
    Get full text
    Journal Article
  7. 7

    Alternative to In Vivo Tests During the COVID-19 Pandemic: Multiple Allergen Simultaneous Tests as a Useful First Screening by Bartolome, Clara San, Farre, Victor, Rius, Josefina, Torradeflot, Maria, Espanol-Rego, Marta, Pascal, Mariona

    Published in Clinical laboratory (Heidelberg) (01-01-2021)
    “…In allergy diagnosis we sometimes find some clinical or logistic limitations to be able to carry out in vivo tests, so the detection of serum allergic-specific…”
    Get more information
    Journal Article
  8. 8
  9. 9
  10. 10

    Low Levels Matter: Clinical Relevance of Low Pru p 3 sIgE in Patients With Peach Allergy by Balsells-Vives, Sara, San Bartolomé, Clara, Casas-Saucedo, Rocío, Ruano-Zaragoza, María, Rius, Josefina, Torradeflot, Maria, Bartra, Joan, Munoz-Cano, Rosa, Pascal, Mariona

    Published in Frontiers in allergy (05-04-2022)
    “…Many clinical lab settings still use 0.35 KU /L as the cut-off for serum specific-IgE (sIgE) immunoassays, while the detection limit is 0.1 KU /L. The clinical…”
    Get full text
    Journal Article
  11. 11
  12. 12

    CART manufacturing process and reasons for academy-pharma collaboration by Egri, Natalia, Ortiz de Landazuri, Iñaki, San Bartolomé, Clara, Ortega, J. Ramón, Español-Rego, Marta, Juan, Manel

    Published in Immunology letters (01-01-2020)
    “…•CAR technology is more than a promising immunotherapy; it is a reality.•Number of clinical trials testing academic and industry CARs are…”
    Get full text
    Journal Article
  13. 13
  14. 14
  15. 15